Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-09-04 Sale | 2025-09-08 6:15 pm | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 18,229 | $20.34 | $370,837 | 152,504 (Direct) | View |
2025-09-02 Sale | 2025-09-04 6:45 pm | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 848 | $18.86 | $15,996 | 33,284 (Direct) | View |
2025-08-19 Sale | 2025-08-20 9:30 pm | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 16,158 | $16.61 | $268,376 | 101,216 (Direct) | View |
2025-06-02 Sale | 2025-06-04 7:30 pm | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 868 | $17.89 | $15,529 | 34,132 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-09-04 Exercise | 2025-09-08 6:15 pm | N/A N/A | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 16,160 | $5.1 | 152,504 (Direct) | View |
2025-09-04 Exercise | 2025-09-08 6:15 pm | N/A 2033-07-26 | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 16,160 | $0 | 152,504 (Direct) | View |
2025-08-19 Exercise | 2025-08-20 9:30 pm | N/A N/A | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 16,158 | $5.1 | 101,216 (Direct) | View |
2025-08-19 Exercise | 2025-08-20 9:30 pm | N/A 2033-07-26 | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 16,158 | $0 | 101,216 (Direct) | View |
2025-02-27 Option Award | 2025-03-03 5:45 pm | N/A 2035-02-26 | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 87,000 | $0 | 87,000 (Direct) | View |
2025-01-31 Option Award | 2025-02-03 8:30 pm | N/A 2033-07-26 | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 225,435 | $0 | 225,435 (Direct) | View |
2025-01-29 Option Award | 2025-01-31 4:31 pm | N/A 2035-01-28 | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 47,775 | $0 | 47,775 (Direct) | View |
Ownership | 2025-01-29 9:43 pm | N/A 2033-07-26 | Beta Bionics Inc. | BBNX | Hopman Mark Chief Commercial Officer | 0 | $0 | 177,660 (Direct) | View |